Chatterjee-Kishore Moitreyee
Wyeth Research, Biological Technologies, Cambridge, MA 02140, USA.
Curr Opin Drug Discov Devel. 2006 Mar;9(2):231-9.
Comprehensive, high-throughput analysis of gene function using RNA interference (RNAi)-based screens is emerging as a significant step forward for preliminary drug-target identification. Until quite recently drug target identification depended heavily on the analysis of changes in gene expression, which in turn needed to be correlated with gene function. The promise of obtaining preliminary 'gene to phenotype' information using a single high-throughput platform is propelling major investment in this area by biotechnology and pharmaceutical companies. This review discusses recent developments in the use of RNAi library screens, and the various assay formats and techniques currently in use for data analysis downstream of such screens.
利用基于RNA干扰(RNAi)的筛选技术对基因功能进行全面、高通量分析,正成为初步药物靶点识别向前迈出的重要一步。直到最近,药物靶点识别还严重依赖于基因表达变化的分析,而这又需要与基因功能相关联。利用单一高通量平台获取初步“基因到表型”信息的前景,正促使生物技术和制药公司在这一领域进行大量投资。本文综述了RNAi文库筛选应用的最新进展,以及目前用于此类筛选下游数据分析的各种检测形式和技术。